News zum Sektor Gesundheit aus Australien

 

MELBOURNE, Australia and INDIANAPOLIS, Ind., April 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) ("Telix") today launches an offering of US$550 million convertible notes due 2031 to be issued by its wholly-owned subsidiary, Telix Pharmaceuticals......

Investors are balancing Clarity's long-term potential against near-term uncertainty. The post Why Clarity Pharmaceuticals shares just fell 5% on today's announcement appeared first on The Motley Fool Australia....

Two major US contract wins in as many weeks could mark a turning point in sentiment. The post Still down 40%, are Pro Medicus shares primed to break out? appeared first on The Motley Fool Australia....

Find insight on GSK, Sigma Healthcare and more in the latest Market Talks covering the Health Care sector....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

CANBERA (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) and Telix Pharmaceuticals Ltd. (TLX, TLX.AX) announced Monday a collaboration to jointly develop and commercialize next generation radiop......

Telix and Regeneron Pharmaceuticals have entered a partnership for the development and commercialisation of new radiopharmaceutical therapies. This collaboration aims to integrate Telix's expertise in radiopharmaceutical platforms, global The post Telix and Regeneron to co-develop radiopharmaceutical therapies appeared first on Pharmaceutical Business review....

MELBOURNE, Australia and INDIANAPOLIS and TARRYTOWN, N.Y., April 13, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN, “Regeneron”) today announce a collaboration to jointly develop and commercialize next generation radiopharmaceutical therapies....

Regeneron and Telix to co-develop and co-commercialize next-generation radiopharmaceutical therapies in a 50/50 cost and profit-sharing model ...

CANBERA (dpa-AFX) - Telix Pharmaceuticals Limited (TLX, TLX.AX) and Regeneron Pharmaceuticals, Inc. (REGN) have announced a collaboration to jointly develop and commercialize next-generation radio......

These shares are starting the week in a positive fashion. But why? The post Why Monash IVF, Pro Medicus, Telix, and Woodside shares are storming higher today appeared first on The Motley Fool Australia....

Investors are snapping up Telix shares on Monday following big US news. The post Telix share price leaping higher today on $3 billion US news appeared first on The Motley Fool Australia....

This tech stock is on the move on Monday after announcing another contract win. The post Why are Pro Medicus shares outperforming the market on Monday? appeared first on The Motley Fool Australia....

Pro Medicus has renewed its major contract with Northwestern Medicine, locking in higher fees and strengthened client ties for the next five years. The post Pro Medicus locks in 5-year, $37m Northwestern Medicine contract renewal appeared first on The Motley Fool Australia....

Telix Pharmaceuticals has announced a US$40m strategic collaboration with Regeneron for innovative radiopharmaceutical cancer therapies. The post Telix Pharmaceuticals announces US$40m Regeneron radiopharma deal appeared first on The Motley Fool Australia....

When two quality shares diverge, I think it is worth taking a closer look. The post Better buy? CSL vs Rio Tinto shares appeared first on The Motley Fool Australia....

Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness efforts ...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

FDA accepts Telix NDA for Pixclara for brain cancer imaging, analysts see confidence rebuild amid steady sales growth. Importance Rank:  1 read more...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...